Semaglutide is a long-acting GLP-1 receptor agonist and one of the most extensively characterised compounds in metabolic research. This guide gives a research-level overview.
What is Semaglutide?
Semaglutide is a peptide analogue of GLP-1 (glucagon-like peptide-1), an incretin hormone. Structural modifications give it a long half-life compared with native GLP-1. It is supplied as lyophilised vials and pre-filled research pens.
What Semaglutide is studied for
As a single-receptor GLP-1 agonist, Semaglutide is studied in laboratory models of glucose regulation, appetite signalling and energy balance. Because it is so well characterised, it is often used as a reference compound against newer dual and triple agonists — see our Semaglutide vs Tirzepatide vs Retatrutide comparison and the wider guide to GLP-1 research peptides.
Forms and handling
Vials are reconstituted with bacteriostatic water per our reconstitution guide; pens are supplied ready to handle. Follow the storage guide for stability.
Quality and verification
Every batch is HPLC- and MS-verified to ≥ 99% purity with a batch COA. See the Semaglutide product or the GLP-1 Research Peptides category.
Related guides
- A Guide to GLP-1 Research Peptides
- How to Reconstitute Research Peptides
- How to Store Research Peptides
Research use only. This guide is informational, for qualified researchers. GenoPept products are supplied strictly for in-vitro laboratory and scientific research and are not for human or veterinary use.